SynthesisFrontiers in pharmacology2022

Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents.

Octavian VasiliuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.